Application

14389237 · S100A8/A9 as a Diagnostic Marker and a Therapeutic Target

Filed 2014-09-29 · Abandoned The official file ↗ · Art unit 1642 · Examiner Mark Halvorson Typical · CPC C12Q 1/6886 · Sloan-Kettering Institute for Cancer Research · Larson & Anderson, LLC

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

18.9 mo

to disposition 53.7 mo

Statutes raised

101 103 112

4 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.